Evidence of hypoxic areas within the arterial wall in vivo

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 870-876

  Björnheden, Tom ^a   Levin, M ^a   Evaldsson, M ^a   Wiklund, O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Artery; Atherosclerosis; Hypoxia; Hypoxia marker

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; FOAM CELL; HYPOXEMIA; HYPOXIA; IMMUNOFLUORESCENCE; MALE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN TENSION; PRIORITY JOURNAL; RABBIT;

EID: 0040034149     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.870     Document Type: Article

References (37)

1. Hueper WC. General reviews. Arterioscler Arch Pathol. 1944;38: 162-181.
2. Morrison ES, Scott RF, Kroms M, Frick J. Glucose degradation in normal and atherosclerotic aortic intima-media. Atherosclerosis. 1972;16: 175-184.
3. Björnheden T, Bondjers G. Studies on oxygen consumption in aortic tissue from rabbits with dietarily induced atherosclerosis. Arteriosclerosis. 1987;7:238-247.
4. Niinikoski J, Heughan C, Hunt TK. Oxygen tensions in the aortic wall of normal rabbits. Atherosclerosis. 1973;17:353-359.
5. Jurrus ER, Weiss HS. In vitro tissue oxygen tensions in the rabbit aortic arch. Atherosclerosis. 1977;28:223.
6. Crawford DW, Kramsch DM. The oxygen environment of the arterial media in early rabbit hypertension. Exp Mol Pathol. 1988;49:215-233.
7. Zemplenyi T, Crawford DW, Cole MA. Adaptation to arterial wall hypoxia demonstrated in vivo with oxygen microcathodes. Atherosclerosis. 1989;76:173-179.
8. Björnheden T, Evaldsson M, Wiklund O. A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arterioscler Thromb Vasc Biol. 1996;16:178-185.
9. Hodgkiss RJ, Jones G, Long A, Patrick J, Smith KA, Stratford MRL, Wilson GD. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer. 1991; 63:119-125.
10. Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer. 1981;43: 546-550.
11. Franko AJ. Misonidazole and other hypoxia markers: metabolism and applications. Int J Radiat Oncol. 1986;12:1195-1202.
12. Hodgkiss RJ, Kelleher E, Parrick J. Hypoxia specific inhibition of recovery from radiation damage by a novel 2-nitroimidazole with a theophylline side chain. Int J Radiat Biol. 1992;61:797-804.
13. Koh W, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn KA, Griffin TW. Imaging of hypoxia in human tumours with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys. 1992;22: 199-212.
14. van Geel IPJ, Oppelaar H, Rijken PFJW, Bernsen HJJA, Hagemeier NEM, van der Kogel AJ, Hodgkiss RJ, Stewart FA. Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br J Cancer. 1996;73:288-293.
15. Joseph P, Jaiswal AK, Stobbe CC, Chapman JD. The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles. Int J Radiat Oncol Biol Phys. 1994;29:351-355.
16. Baumgartner HR. Eine neue Methode zur Erzeugung von Thromben durch gezielte Überdehnung der Gefässwand. Z Ges Exp Med. 1963;137: 227-232.
17. Schwenke DC, Zilversmit DB. The arterial barrier to lipoprotein influx in the hypercholesterolemic rabbit. 1: studies during the first two days after mild aortic injury. Atherosclerosis. 1989;77:99-103.
18. Björnheden T, Bylock A, Hansson GK, Bondjers G. A system for long-term perfusion of rabbit aorta in vitro. Arteriosclerosis. 1983;3: 366-382.
19. McElroy DA. Connective tissue. In: Prophet EB, Mills B, Arrington JB, Sohin LH, eds. Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1994.
20. Hodgkiss RJ, Stratford MRL, Dennis MF, Hill SA. Pharmacokinetics and binding of the bioreductive probe for hypoxia. NITP: effect of route of administration. Br J Cancer. 1995;72:1462-1468.
21. Chapman JD, Baer K, Lee J. Characteristics of metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 1983; 43:1523-1528.
22. Deleted in proof.
23. Deleted in proof.
24. 2? Biochem Pharmacol. 1987;36: 3487-3494.
25. MacManus MP, Maxwell AP, Abram WP, Bridges JM. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice. Br J Cancer. 1989;59:349-352.
26. Garrecht BM, Chapman JD. The labelling of EMT-6 tumours in BALB/C mice with. 14C-misonidazole. Br J Radiat. 1983;56:745-753.
27. Cobb LM, Path FR, Nolan JN, Hacker T. Retention of misonidazole in normal and malignant tissues: interplay of hypoxia and reductases. Int J Radiat Oncol Biol Phys. 1992;22:655-659.
28. Cobb LM, Hacker T, Nolan J. NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole. Br J Cancer. 1990;61:524-529.
29. Parliament MB, Wiebe LI, Franko AJ. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells. Br J Cancer. 1992;66:1103-1108.
30. Maxwell AP, MacManus MP, Gardiner TA. Misonidazole binding in murine liver tissue: a marker for cellular hypoxia in vivo. Gastroenterology. 1989;97:1300-1303.
31. Arteel GE, Raleigh JA, Bradford BU, Thurman RG. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am J Physiol. 1996;271:G494-G500.
32. Arteel GE, Thurman RG, Yates JM, Raleigh JA. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 1995;72:889-895.
33. Mitchell JA, Kohlhaas KL, Matsumoto T, Pollock JS, Förstermann U, Warner TD, Schmidt HHHW, Murad F. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages. Mol Phannacol. 1992;41:1163-1168.
34. Deleted in proof.
35. 3H-misonidazole labelling and viability of hypoxic cells in the sandwich system, an in vitro tumour analogue. Int J Radiat Oncology Biol Phys. 1989;16:143-153.
36. Rasey JS, Koh W, Grierson JR, Grunbaum Z, Krohn KA. Radiolabelled fluoromisonidazole as an imaging agent for tumour hypoxia. Int J Radiat Oncology Biol Phys. 1989;17:985-991.
37. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density on multicellular spheroids. Int J Cancer. 1995;61:567-573